Menu
Back to Journals » Clinical and Experimental Gastroenterology » Volume 5 » default
ISSN: 1178-7023
- View all (574)
- Volume 18, 2025 (11)
- Volume 17, 2024 (30)
- Volume 16, 2023 (26)
- Volume 15, 2022 (20)
- Volume 14, 2021 (51)
- Volume 13, 2020 (59)
- Volume 12, 2019 (44)
- Volume 11, 2018 (47)
- Volume 10, 2017 (34)
- Volume 9, 2016 (38)
- Volume 8, 2015 (34)
- Volume 7, 2014 (46)
- Volume 6, 2013 (28)
- Volume 5, 2012 (23)
- Volume 4, 2011 (32)
- Volume 3, 2010 (26)
- Volume 2, 2009 (20)
- Volume 1, 2008 (5)
Archive: Volume 5, 2012
A plausible explanation for male dominance in typhoid ileal perforation
Khan M
Clinical and Experimental Gastroenterology 2012, 5:213-217
Published Date: 12 November 2012
Burden of constipation-predominant irritable bowel syndrome (IBS-C) in France, Italy, and the United Kingdom
DiBonaventura MD, Prior M, Prieto P, Fortea J
Clinical and Experimental Gastroenterology 2012, 5:203-212
Published Date: 8 November 2012
Increased wall thickness using ultrasonography is associated with inflammation in an animal model of experimental colitis
Lied GA, Milde AM, Nylund K, Mujic M, Grimstad T, Hausken T, Gilja OH
Clinical and Experimental Gastroenterology 2012, 5:195-201
Published Date: 2 October 2012
Development of a simplified diagnostic indicators scoring system and validation for peptic ulcer perforation in a developing country
Suriya C, Kasatpibal N, Kunaviktikul W, Kayee T
Clinical and Experimental Gastroenterology 2012, 5:187-194
Published Date: 25 September 2012
Gut bacterial profile in patients newly diagnosed with treatment-naïve Crohn's disease
Ricanek P, Lothe SM, Frye SA, Rydning A, Vatn MH, Tønjum T
Clinical and Experimental Gastroenterology 2012, 5:173-186
Published Date: 24 September 2012
Retrospective analysis of KRAS status in metastatic colorectal cancer patients: a single-center feasibility study
Montomoli J, Hamilton-Dutoit SJ, Frøslev T, Taylor A, Erichsen R
Clinical and Experimental Gastroenterology 2012, 5:167-171
Published Date: 18 September 2012
Role of XPC, XPD, XRCC1, GSTP genetic polymorphisms and Barrett’s esophagus in a cohort of Italian subjects. A neural network analysis
Tarlarini C, Penco S, Conio M, Grossi E
Clinical and Experimental Gastroenterology 2012, 5:159-166
Published Date: 8 August 2012
Update on triple therapy for eradication of Helicobacter pylori: current status of the art
Urgesi R, Cianci R, Riccioni ME
Clinical and Experimental Gastroenterology 2012, 5:151-157
Published Date: 17 September 2012
Polyethylene glycol versus dual sugar assay for gastrointestinal permeability analysis: is it time to choose?
van Wijck K, Bessems BAFM, van Eijk HM, Buurman WA, Dejong CH, Lenaerts K
Clinical and Experimental Gastroenterology 2012, 5:139-150
Published Date: 19 July 2012
Evaluation of protective effect of Sapindus mukorossi saponin fraction on CCl4-induced acute hepatotoxicity in rats
Srinivasa Rao M, Syed Asad B, Fazil MA, Sudharshan RD, Rasheed SA, Pradeep HA, Aboobacker S, Thayyil AH, Riyaz AK, Mansoor M, Aleem MA, Zeeyauddin K, Lakshmi Narasu M, Anjum A, Ibrahim M
Clinical and Experimental Gastroenterology 2012, 5:129-137
Published Date: 17 July 2012
Age-dependent safety analysis of propofol-based deep sedation for ERCP and EUS procedures at an endoscopy training center in a developing country
Amornyotin S, Leelakusolvong S, Chalayonnawin W, Kongphlay S
Clinical and Experimental Gastroenterology 2012, 5:123-128
Published Date: 9 July 2012
Lactose intolerance: diagnosis, genetic, and clinical factors
Mattar R, Mazo DF, Carrilho FJ
Clinical and Experimental Gastroenterology 2012, 5:113-121
Published Date: 5 July 2012
Newer agents for Helicobacter pylori eradication
Fiorini G, Zullo A, Gatta L, Castelli V, Ricci C, Cassol F, Vaira D
Clinical and Experimental Gastroenterology 2012, 5:109-112
Published Date: 18 June 2012
Barrier effect of Esoxx® on esophageal mucosal damage: experimental study on ex-vivo swine model
Di Simone MP, Baldi F, Vasina V, Scorrano F, Bacci ML, Ferrieri A, Poggioli G
Clinical and Experimental Gastroenterology 2012, 5:103-107
Published Date: 11 June 2012
Is long-lasting mucosal elevation the only valid parameter when evaluating a lifting agent?
Pontone S, Manfredelli S, Krizzuk D, Leonetti G
Clinical and Experimental Gastroenterology 2012, 5:101-102
Published Date: 1 June 2012
Targeted therapies for diarrhea-predominant irritable bowel syndrome
Olden KW
Clinical and Experimental Gastroenterology 2012, 5:69-100
Published Date: 25 May 2012
Gelatin tannate reduces the proinflammatory effects of lipopolysaccharide in human intestinal epithelial cells
Frasca G, Cardile V, Puglia C, Bonina C, Bonina F
Clinical and Experimental Gastroenterology 2012, 5:61-67
Published Date: 8 May 2012
Efficacy of esomeprazole in treating acid-related diseases in Japanese populations
Sugimoto M, Furuta T
Clinical and Experimental Gastroenterology 2012, 5:49-59
Published Date: 14 May 2012
Efficacy of submucosal injection of different solutions inclusive blood components on mucosa elevation for endoscopic resection
Al-Taie OH, Bauer Y, Dietrich CG, Fischbach W
Clinical and Experimental Gastroenterology 2012, 5:43-48
Published Date: 17 April 2012
DCLK1 immunoreactivity in colorectal neoplasia
Gagliardi G, Goswami M, Passera R, Bellows CF
Clinical and Experimental Gastroenterology 2012, 5:35-42
Published Date: 11 April 2012
Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori
Gisbert JP, Calvet X
Clinical and Experimental Gastroenterology 2012, 5:23-34
Published Date: 13 March 2012
Differences in clinical outcomes among hepatitis C genotype 1-infected patients treated with peginterferon alpha-2a or peginterferon alpha-2b plus ribavirin: a meta-analysis
Druyts E, Mills EJ, Nachega J, O'Regan C, Cooper CL
Clinical and Experimental Gastroenterology 2012, 5:11-21
Published Date: 14 February 2012
Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: a review
Mangel AW, Hicks GA
Clinical and Experimental Gastroenterology 2012, 5:1-10
Published Date: 12 January 2012